# The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission

> **NCT06799949** · — · ACTIVE_NOT_RECRUITING · sponsor: **Kotoulas Serafeim-Chrysovalantis** · enrollment: 50 (estimated)

## Conditions studied

- Heparinization

## Interventions

- **DIAGNOSTIC_TEST:** ROTEM (TEM Innovations GmbH, Munich, Germany) assay

## Key facts

- **NCT ID:** NCT06799949
- **Lead sponsor:** Kotoulas Serafeim-Chrysovalantis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-14
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799949, "The Role of Endogenous Heparinization As an Intraoperative Predictive Marker for Postoperative ICU Admission". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06799949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*